Furosemide NDC 0054-4299

NDC codes

FDA NDC Directory

Product NDC (as listed)0054-4299Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00054-4299Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0054-4299-25	00054429925	100 TABLET in 1 BOTTLE (0054-4299-25)Marketed from Nov 10, 1983
0054-4299-31	00054429931	1000 TABLET in 1 BOTTLE (0054-4299-31)Marketed from Nov 10, 1983

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018823
Marketing start: Nov 10, 1983
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 0054-4299_bc62ddda-7639-4090-99f0-7dd4d13518f3SPL ID bc62ddda-7639-4090-99f0-7dd4d13518f3SPL set ID 9e493331-dddd-496e-abf8-61747fb67abaRxCUI 197730, 197731, 197732, 310429, 313988UNII 7LXU5N7ZO5UPC 0300544301251, 0300544299251, 0300544297257, 0300543298637
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400054429925 followed by a unit qualifier and the quantity

Package 00054-4299-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 3, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018823

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018823
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 20 mg/1	TabletOral	Northwind Health Company, LLC	51655-481
Furosemide	Furosemide 40 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	43353-069
Furosemide	Furosemide 20 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	43353-747
Furosemide	Furosemide 20 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-8297
Furosemide	Furosemide 20 mg/1	TabletOral	A-S Medication Solutions	50090-6219
Furosemide	Furosemide 40 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-8299
Furosemide	Furosemide 20 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-4297